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1276 The Journal of Thoracic and CardObjective: Background data were obtained on all California hospitals performing
coronary artery bypass grafting and percutaneous coronary intervention procedures
and compared with reports published by the state of New York to develop a
collaborative quality improvement program for cardiac surgery programs.
Methods: The Patient Discharge Database of the Office of Statewide Health Plan-
ning and Development was queried for the years 1999-2001. In-hospital mortality
and risk factors for coronary artery bypass grafting and percutaneous coronary
intervention were obtained by using demographic data and International Classifi-
cation of Diseases–Ninth Revision–Clinical Modification procedure and diagnosis
codes. Risk models were developed by means of logistic regression analysis.
Results: Overall coronary artery bypass grafting mortality was 33% higher and
percutaneous coronary intervention mortality was twice as high in California com-
pared with that in New York. Procedural volume (per unit population) was higher
in New York. In high-volume California hospitals (300 procedures per year),
coronary artery bypass grafting mortality was similar (California, 2.42%; New
York, 2.25%). Excess coronary artery bypass grafting mortality (4.0%) occurred
only in low-volume programs. Risk adjustment did not change the volume effect for
coronary artery bypass grafting. No volume effect was noted for risk-adjusted
percutaneous coronary intervention mortality. There were no obvious differences in
risk factors between California and New York. Programs performing relatively
fewer coronary artery bypass grafting procedures compared with percutaneous
coronary interventions were found to have significantly higher coronary artery
bypass grafting mortality after adjusting for volume effects. Percutaneous coronary
intervention volume is increasing and coronary artery bypass grafting volume is
decreasing in both California and New York.
Conclusions: Excess coronary artery bypass grafting mortality in California is
related to the large number of low-volume programs. Excess percutaneous coronary
intervention mortality might be related to case selection or timing of intervention. A
relationship between percutaneous coronary intervention volume and coronary
artery bypass grafting mortality is suggested in which increasing percutaneous
coronary intervention volume relative to coronary artery bypass grafting volume
might have the effect of shifting patients with undefined higher risk characteristics
to coronary artery bypass grafting.
In-hospital mortality is often used as a surrogate for quality in performanceevaluation of medical and surgical services. In response to increasing expendi-tures for surgical procedures, such as coronary artery bypass grafting (CABG),
and concerns about the availability and accuracy of provider-specific comparative
data, mandatory reporting programs have been implemented in several states. New
York has had a program managed by the New York State Department of Health in
iovascular Surgery ● June 2005
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years, which currently includes public release of hospital-
and physician-specific mortality for all cardiac surgery and
coronary interventional procedures. California has had a
program that requires reporting of outcomes of all hospital
admissions to the Office of Statewide Health Planning and
Development (OSHPD). However, there has been no re-
quirement of reporting in-hospital mortality to the public
until a recent upgrade of the law was passed (California
Senate Bill 680).
The California Society of Thoracic Surgeons (CASTS),
as well as the California Chapter of the American College of
Cardiology and the California Medical Association, sup-
ported the mandatory reporting law. The medical groups
were able to participate in the appointment of 6 physicians
to the 9-member Cardiac Advisory Board. A critical review
process was required to allow individual approval by each
physician whose data were to be reported to the public. The
law, however, requires only reporting of CABG in-hospital
mortality. Recognizing that reporting of mortality does not
constitute a quality improvement program, officials at OSHPD
asked the CASTS to develop one.
The California Cardiac Surgery Initiative (CCSI) was
established by the CASTS and the California Healthcare
Foundation as a voluntary collaborative quality improve-
ment program to facilitate compliance with SB-680, to
review outcomes, and to share best practices. An initial goal
was to examine background data on all hospitals performing
cardiac surgery and interventional coronary procedures in
California.
The outcome data accumulated by OSHPD, know as the
patient discharge database (PDD), can be queried for re-
search purposes. We recently queried the PDD to study the
relationship between hospital volume and outcome across
California hospitals performing cardiac surgery.1 We noted
that the in-hospital mortality of CABG and percutaneous cor-
onary intervention (PCI) procedures was higher in California
compared with that reported by New York. The present
report further examines this observation and attempts to
explain its potential causes.
Methods
The OSHPD PDD is an administrative database aggregated from a
2-page “patient discharge abstract” produced from the clinical record
of every patient discharged from an acute- or subacute-care facility.
Demographic data and International Classification of Diseases–Ninth
Revision–Clinical Modification (ICD-9-CM) diagnosis and procedure
codes are abstracted by medical record personnel. The OSHPD PDD
was queried for the years 1997 through 2001 by using ICD-9-CM
codes to identify cardiac surgical and interventional procedures
performed in California. For the present report, CABG only was
selected as 36.10 through 36.19, excluding other cardiac surgical
codes (35.10-35.39, 35.50-35.95, 37.31-37.5, 38.35, 38.45, and
33.6); PCI only was selected as 36.01, 36.02, 36.05, 36.06, and
The Journal of Thoracic36.09, excluding 36.10 through 36.19 and other cardiac surgical
codes. A patient having PCI and CABG during the same hospi-
talization was included in the CABG group, as is the custom in
New York.
Risk factors used for risk models were determined by using
diagnosis codes. We used logistic regression analysis to determine
the effect of risk factors on the mortality outcomes. The following
demographic risk factors were analyzed: age categorized as 18 to
39, 40 to 44, 45 to 49, 50 to 54, 55 to 59, 60 to 64, 65 to 69, 70
to 74, 75 to 79, 80 to 84, 85 to 89, and 90 years or older (treating
age as a continuous variable in the regression model led to the
same conclusions); race categorized as white, black, Asian–Pacific
Islander, and “other”; ethnicity categorized as non-Hispanic and
Hispanic; and sex categorized as male and female. The models also
included the following clinical risk factors (if applicable, ICD-
9-CM codes are shown in parentheses): dialysis (39.95, 54.98);
diabetes (250.xx); cerebrovascular disease (430.xx-438.xx);
chronic obstructive pulmonary disease (490.xx, 494.xx, 496.xx);
peripheral vascular disease (440.xx, 441.2x, 441.4x, 441.7x,
441.9x, 443.1x, 443.8x, 443.9x, 447.1x, 557.1x, 557.9x, v43.4x);
renal failure (403.11, 403.91, 404.12, 404.92, 585.xx, 586.xx,
v42.0x, v45.1x, v56.0x, v56.8x); cardiomyopathy (425.xx); car-
diogenic shock (785.51); acute myocardial infarction (410.xx,
admitted through the emergency department); congestive heart
failure (428.0x, 428.1x, 428.9x, 398.91, 402.21, 402.11, 404.03,
404.11, 404.13, 404.91, 404.93); prior CABG surgery (V45.81);
emergency status (unscheduled admission through emergency de-
partment with procedure performed on admission date); prior PCI
(for CABG model); PCI performed on same date as CABG; heart
catheterization (for CABG model); and heart catheterization per-
formed on same date as CABG.
New York data were obtained from information published on
the New York State Department of Health Web site. We used the
most recent reports for CABG (1999-2001) and PCI (1999-2001).
The New York data are abstracted from the clinical record, includ-
ing the risk factors. The continuity-adjusted 2 test was used to
determine differences in rates between California and New York.
Results
Incidence and Mortality
Table 1 shows the incidence and observed in-hospital mor-
tality rate of CABG and PCI procedures in California and
New York for the time periods studied. CABG mortality
was 33% higher in California, and PCI mortality was nearly
twice as high. Procedure performance rates were signifi-
cantly higher in New York for both CABG and PCI (P 
.0001): in New York 3.0% of the population undergoes
either CABG or PCI compared with California, where the
percentage is 2.3%.
Procedural Volume
During the periods studied, there were 121 hospitals per-
forming CABG and PCI procedures in California; an addi-
tional 17 hospitals performed PCI without CABG facilities.
In New York 34 hospitals performed CABG and PCI, and 5
performed PCI alone. Procedural volume and mortality
rates for hospitals performing both CABG and PCI are
and Cardiovascular Surgery ● Volume 129, Number 6 1277
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hospitals in California, all performing more than 300 CABG
procedures per year (average, 516 procedures), had an in-
hospital mortality of 2.42% for the 3-year period, which is
comparable with that of New York, with an average volume
of 521 procedures per year and a mortality of 2.25% (P 
.32). However, for PCI, high-volume hospitals (600 pro-
cedures per year) still had significantly higher mortality in
California (1.22%) compared with that in New York
(0.76%, P  .0001). Risk-adjusted mortality rates reduced
the volume effect slightly for CABG mortality and elimi-
nated it for PCI mortality in California.
Risk Factor Comparison
Table 3 shows selected risk factors for CABG mortality
published by the New York State Department of Health in
comparison with the California data. Age is reported as
“number of years greater than 60” by New York, which is
TABLE 1. Incidence and outcome of CABG and PCI proce-
dures
California New York
Population (year 2000) 33,871,648 18,976,457
CABG, n (1999-2001) 82,353 53,220
CABG/1000 persons/y 0.81 0.93
PCI, n (1999-2001) 153,755 117,878
PCI/1000 persons/y 1.51 2.07
CABG mortality, n (%) 2431 (2.93) 1197 (2.2
PCI mortality, n (%) 2197 (1.43) 896 (0.76
Note: All differences in rates betweenCalifornia and New York shown in
the table are statistically significant ( P  .0001). CABG, Coronary artery
bypass grafting; PCI, percutaneouscoronary intervention.
TABLE 2. Procedural volume and mortality
Procedure group
No. of
sites
Average no. of
procedures/y
Mortality, %
(RAMR)
CA-CABG 300/y 26 516 2.42 (2.58)
CA-CABG 300 y 95 148 3.43 (3.22)
NY-CABG 34 521 2.25 (2.25
CA-PCI 600/y 22 871 1.22 (1.41)
CA-PCI 600/y 116 321 1.53 (1.39)
NY-PCI 39 1007 0.76 (0.76
Note: Mortality for high-volume California hospitals is not statisticall
significant from mortality in New York hospitals. Mortality in low-volum
California hospitals is statistically significantly higher compared with that
in (1) high-volume California hospitals or (2) New York hospitals. P
mortality in low-volume California hospitals is statistically significantl
higher compared with that in (1) high-volume California hospitals or (2
New York hospitals. Furthermore, PCI mortality in high-volume Californ
hospitals is statistically significantly higher compared with that in New
York hospitals.RAMR, Risk-adjusted mortality rate;CA, California; CABG,
coronary artery bypass grafting; NY, New York; PCI, percutaneouscoro-
nary intervention.
1278 The Journal of Thoracic and Cardiovascular Surgery ● Junnot comparable with California grouped data, but in both
states, older age has a significant effect on mortality. Of
note is the lack of significance of diabetes as a risk factor in
California and the greater significance of female sex in New
York. There are fewer emergency and shock cases, a higher
incidence of CVD, and a lower incidence of renal failure in
New York. We also found that heart catheterization or PCI
performed on the same day as CABG significantly affected
in-hospital mortality, but these factors were not published in
New York reports.
Table 4 shows selected risk factors for PCI mortality
published by New York compared with California data. Age
was reported as “number of years greater than 55” for PCI,
which is not comparable with California grouped data, but
TABLE 3. Comparison of selected risk factors: CABG, 1999-
2001
Prevalence Odds ratio
CA NY P value CA NY
Female sex 27.6 28.5 .003 1.37 1.87
Diabetes 32.9 32.6 .2505 0.93 1.59
Emergency 1.83 1.10 .0001 2.37 3.54
Shock 0.96 0.42 .0001 7.75 9.00
CVD 6.84 18.8 .0001 1.23 1.77
COPD 13.6 16.6 .0001 1.45 1.99
PVD 9.76 10.9 .0001 1.41 1.94
Renal failure 3.49 1.96 .0001 3.13 2.83
Dialysis 1.15 1.44 .0001 1.68 6.22
Prior CABG 3.41 5.36 .0001 2.35 4.12
CHF or low EF 15.2 22.1 .0001 2.06 1.90-3.50
CA, California; NY, New York; CVD, cerebrovascular disease; COPD,
chronic obstructive pulmonary disease; PVD, peripheral vascular disease;
CABG, Coronary artery bypass grafting; CHF, congestive heart failure; EF,
ejection fraction.
TABLE 4. Comparison of selected risk factors: PCI, 1999-
2001
Prevalence (%) Odds ratio
CA NY P value CA NY
Female sex 33.0 31.9 .0001 1.25 2.88
Diabetes 25.0 — — 1.28 —
Emergency 12.9 9.9 .0001 2.37 —
Shock 1.17 0.29 .0001 19.23 33.0
CVD 2.64 7.22 .0001 1.50 3.08
COPD 8.23 5.53 .0001 1.51 3.10
PVD 6.22 5.72 .0001 1.54 3.54
Renal failure 2.85 1.17 .0001 2.58 5.77
Dialysis 0.99 1.20 .0001 2.23 8.26
CHF or low EF 10.9 11.0 .4080 1.93 3.06
CA, California; NY, New York; CVD, cerebrovascular disease; COPD,
chronic obstructive pulmonary disease; PVD, peripheral vascular disease;
CHF, congestive heart failure; EF, ejection fraction.
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states. Diabetes was not reported, and therefore we can
assume that it was not a significant risk factor for PCI.
Emergency presentation was reported separately by New
York for the years 1999-2001; the observed mortality rate
was 4.16% compared with 3.86% for the emergency pre-
sentation group in California. As noted in CABG proce-
dures, there were somewhat fewer emergency and shock
patients in New York. Again we see a higher incidence of
CVD and a lower incidence of renal failure.
Risk-Adjusted Mortality and Volume Among
California Hospitals
The wide distribution in procedural volume among California
hospitals performing both CABG and PCI is illustrated in
Figure 1. Each point represents the 3-year volume for one
hospital plotted against its risk-adjusted mortality. A vol-
ume term added to the logistic regression model indicating
whether the patient had CABG surgery at a low-volume as
The Journal of Thoracicopposed to a high-volume hospital was highly statistically
significant (odds ratio, 1.29; 95% confidence limits, 1.19-
1.41; P  .0001). The scatter plot for CABG shows that the
hospitals with a risk-adjusted mortality of greater than 4.0%
all performed less than 300 procedures per year.
Risk adjustment appears to eliminate any effect of vol-
ume on mortality from PCI in California. A volume term
added to the logistic regression model was not statistically
significant in the PCI model.
Increasing Incidence of PCI and Its Effect on CABG
Mortality
Figure 2 illustrates the trend in PCI and CABG procedures
in California and New York. Continuation of the trends
suggests that PCI might represent more than 70% of inter-
ventional procedures used to treat coronary artery disease
by 2004. The increasing incidence of PCI might have an
effect on CABG mortality. The highest-volume hospitals in
Figure 1. A, Risk-adjusted CABG mortality
versus volume. B, Risk-adjusted PCI mor-
tality versus volume.California (600 CABG procedures per year) had the low-
and Cardiovascular Surgery ● Volume 129, Number 6 1279
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lowest risk-adjusted mortality (1.90%). Among the 97 low-
volume (300 CABG procedures per year) hospitals, the
PCI/CABG ratio was 2.37. The relationship of PCI/CABG
ratio to CABG mortality is shown in Figure 3. In our logistic
regression model, after controlling for CABG volume, an
indicator term for a PCI/CABG volume ratio of more than
2.0 as opposed to 2.0 or less was highly statistically signif-
icant (P  .0001).
Discussion
In-hospital mortality for CABG procedures has been used as
a marker for quality of care in cardiac surgery programs
because of the ease of data collection and the accuracy of
the end point. Approximately 70% of cardiac surgery pro-
cedures are CABG, and risk-adjustment methods have been
refined by collection of more complete clinical data sets,
Figure 2. CABG and PCI procedures, California and New York,
1997-2001.1280 The Journal of Thoracic and Cardiovascular Surgery ● Junthus making comparisons across hospitals more appropriate.
Programs introduced in New York and other states have
been associated with reductions in procedural mortality, in
part because monitoring of comparative outcomes encour-
ages quality improvement efforts. Collection of clinical data
sets for purposes of public reporting has, however, raised
concerns about upcoding of risk factors, or avoidance of
performing operations on high-risk patients.
In California a voluntary CABG mortality-reporting pro-
gram was established, but not all hospitals participated, and
there were problems with incomplete data submission and
accuracy of data coding. Sponsored by the Consumers
Union, SB-680 was passed in 2001, requiring mandatory
reporting of all medical, surgical, and obstetric procedures,
beginning with CABG in 2003. The new program estab-
lished a Cardiac Advisory Committee that included repre-
sentatives recommended by the state medical associations.
The CCSI was created as a joint project of the California
Society of Thoracic Surgeons and the California Healthcare
Foundation to assist with compliance with the new law. The
CCSI was conceived as a collaborative quality improvement
program through which all hospitals could monitor out-
comes well before public release and share best practices.
The California medical groups, particularly the thoracic
surgeons, were concerned that CABG represented a de-
creasing percentage of procedures used to treat coronary
artery disease. Therefore the CCSI also sought to create a
database that included background data on all cardiac sur-
gical and interventional procedures performed in California
by using the OSHPD PDD. In a recent report it was found
that during 1997-2001, the incidence of PCI increased 24%
in California.2 Between 1999 and 2001, PCI increased
16.7% in New York. There was little change in the number
of CABG procedures performed during this period until
Figure 3. PCI/CABG ratio versus CABG
mortality.e 2005
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both California and New York.
The higher CABG mortality found in California in rela-
tion to that seen in New York might be related to the large
number of low-volume programs. The highest-volume pro-
grams, averaging more than 500 procedures per year, had
similar mortality in both states. However, volume as an
independent variable has been reported to have a small
effect on CABG mortality. Peterson and associates3 recently
reviewed data from the years 2000 and 2001 in the Society
of Thoracic Surgeons National Database, finding that higher
volume was marginally predictive of lower mortality (ad-
justed odds ratio, 0.98; P  .004). In the present study
hospital volume was more clearly associated with CABG
mortality (adjusted odds ratio for low-volume vs high-
volume hospitals, 1.29; P  .0001). This difference might
be related to the fact that the Society of Thoracic Surgeons
National Database is a voluntary program, whereas all hos-
pitals are included in the California PDD. Hannan and
associates,4 examining mandatory New York data from
1997-1999, found that significantly lower risk-adjusted
mortality rates occurred above all annual hospital volume
thresholds between 200 and 800.
The higher mortality from PCI in California compared
with that in New York is more difficult to explain. Com-
parison of risk factors between the 2 states is confounded by
different methods of data collection. Demographic data
would suggest that the populations are similar overall. For
the most recent census years, the percentage of older (65
years) persons in New York is 13%, and the percentage in
California is 11%. The risk models presented here show
somewhat more patients with vascular disease in New York
and somewhat more patients with acute presentation in
California. These differences could be related to data-coding
procedures.
PCI in-hospital mortality reported by New York is lower
than that reported elsewhere. A recent report from the
Agency for Healthcare Research and Quality Nationwide In-
patient Sample hospital discharge database found in-hospital
mortality to vary from 1.36% for high-volume to 2.56% for
low-volume hospitals.4 A study from the National Heart,
Lung, and Blood Institute Dynamic Registry reported in-
hospital mortality of 1.0% to 3.64%, varying with age
groups.5 In-hospital mortality in Canada during 2000-2001
was 1.4% for PCI.6 In another report from the Nationwide
Inpatient Sample, PCI mortality in 1997 was 0.7% for
stented patients in the absence of acute myocardial infarc-
tion.7 In Scotland, PCI mortality was reported to be 0.3%
during 1997-1999.8 Thus PCI mortality in California is
similar to that reported in most large registries.
Higher procedure performance rates in New York also
suggest that lower PCI mortality is not related to less
aggressive use. Hospital volume also is an unlikely cause
The Journal of Thoracicbecause higher-volume sites in California did not have
better mortality than lower-volume sites. There are more
patients with cardiogenic shock and emergency status in
California. Although these differences are not large, they
might explain some of the findings.
It is more likely that higher PCI mortality in California
might be related to case selection. There might be more
higher-risk patients selected for PCI than for CABG, such as
patients with multivessel disease or complicated lesions.
Basic risk factors might appear to be similar, but these
disease markers are not included in data-coding systems.
One drawback of this study is the comparison of an
administrative and clinical data collection. Although the
accuracy of reporting discharge status and the identification
of isolated CABG surgeries in the California patient dis-
charge data were found to be good,9 one would think that a
risk-adjustment model based on clinical data would outper-
form a risk-adjustment model based on administrative data.
Nonetheless, it is doubtful that the magnitude of the volume
effect can be attributed to a lack of appropriate risk adjust-
ment in the CABG model.
Programs that perform a relatively large number of PCI
procedures and a low volume of CABG procedures might
tend to perform CABG procedures on a more complex
patient population. Our data show that a statistically signif-
icant effect of PCI volume on CABG mortality occurs in
lower-volume hospitals when the PCI/CABG ratio exceeds
2.0. The cause might be related to the reduction in CABG
volume and the increase in patient acuity that necessarily
follows. More straightforward cases are referred for PCI,
and patients with characteristics not defined in risk models,
such as poor vessel quality or diffuse disease, tend to be
referred to CABG.
The PCI/CABG ratio as a potential risk factor for CABG
mortality was alluded to by Starr and associates,10 who
attempted to explain a lower CABG mortality in health
maintenance organization (HMO) referral systems com-
pared with fee-for-service (FFS) systems. Higher patient
acuity in FFS patients only partially explained the differ-
ence. The PCI/CABG ratio was 0.6 in HMO and 1.5 in FFS
patients. CABG mortality was 2.7% (HMO) and 4.6%
(FFS).
Clearly, there are more patients undergoing PCI and
fewer undergoing CABG in both California and New York.
There might be a relationship in case distribution between
PCI and CABG that affects mortality. Further study is
indicated.
Conclusions
We conclude that the higher CABG mortality in California
compared with that in New York is related to the large
number of low-volume programs in California. Hospitals
performing a large number of PCI procedures relative to
and Cardiovascular Surgery ● Volume 129, Number 6 1281
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patient population to CABG. These patients might have
disease characteristics that are not defined by risk models,
such as diffuse multivessel disease that is not amenable to
PCI.
PCI mortality is nearly twice as high in California com-
pared with that in New York. This finding is not related to
risk factors or hospital procedural volume. It might be
related to undefined patient characteristics, patient selection,
or timing of intervention.
Procedure performance rates are higher in New York
compared with those in California. Overall patient risk
appears to be similar in the 2 states.
PCI is increasing (and CABG decreasing) in both California
and New York. PCI will represent more than 70% of revas-
cularization procedures by 2004.
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